ARCHIVES

Progress Measures “Adequate,” Committee Says; Suggestions Include New Death Measure

This article is from The Cancer Letter archive.

Vol. 14 No. 33 | August 12, 1988

Download PDF Visit The Full Archive

Related Articles

In Brief: Owens New President Of AACI, Yates President Elect; UNC Gains Comprehensive Center Status

June 29, 1990

In Brief: Mayo Director Kovach Moves To City Of Hope; Seattle Institutions Win Gene Therapy

May 20, 1994

Ungerleider To Leave NCI For Theradex Corp.

November 24, 2000

Kentucky Okays Cancer Commission, $1 Million Budget

April 21, 1978

FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate.

May 28, 2004

Telatinib Demonstrates Positive Results in First-Line Treatment

June 24, 2011